Finance

Lists
Why is 524372 down 2,50%?
Dive Deeper
524372:BOM
Orchid Pharma Ltd
923,75 ₹
-2,50%
(-23,70) 1D
15 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
945,05 ₹
High
948,00 ₹
Low
923,75 ₹
Mkt. cap
55,39 մլրդ
Avg. vol.
6,88 հզր
Volume
4,05 հզր
52-wk high
1 142,65 ₹
52-wk low
471,30 ₹
No. of employees
1 հզր
Open
945,05 ₹
High
948,00 ₹
Low
923,75 ₹
Mkt. cap
55,39 մլրդ
Avg. vol.
6,88 հզր
Volume
4,05 հզր
52-wk high
1 142,65 ₹
52-wk low
471,30 ₹
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1,17 հզր
Founded1992
Headquarters-
Sector-
Websiteorchidpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,94 մլրդ
2,07 մլրդ
6,59 մլրդ
3,04 մլրդ
Cost of goods sold
1,33 մլրդ
1,43 մլրդ
5,03 մլրդ
2,04 մլրդ
Cost of revenue
1,33 մլրդ
1,43 մլրդ
5,03 մլրդ
2,04 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248,51 մլն
241,28 մլն
502,27 մլն
280,38 մլն
Operating expense
713,95 մլն
715,86 մլն
1,40 մլրդ
968,16 մլն
Total operating expenses
2,04 մլրդ
2,15 մլրդ
6,43 մլրդ
3,01 մլրդ
Operating income
-103,77 մլն
-74,65 մլն
163,81 մլն
30,51 մլն
Other non operating income
107,74 մլն
56,09 մլն
-238,03 մլն
18,28 մլն
EBT including unusual items
-57,24 մլն
-126,14 մլն
131,94 մլն
32,97 մլն
EBT excluding unusual items
-57,24 մլն
-55,01 մլն
54,86 մլն
32,97 մլն
Income tax expense
-
-
17,00 հզր
723,00 հզր
Effective tax rate
-
-
0,01%
2,19%
Other operating expenses
376,43 մլն
384,29 մլն
419,31 մլն
578,29 մլն
Net income
-57,24 մլն
-126,14 մլն
131,92 մլն
32,24 մլն
Net profit margin
-2,96%
-6,09%
2,00%
1,06%
Earnings per share
-1,13
-1,08
4,58
0,54
Interest and investment income
-
-
101,25 մլն
-
Interest expense
-37,32 մլն
-31,78 մլն
-
-22,30 մլն
Net interest expenses
-37,32 մլն
-31,78 մլն
101,25 մլն
-22,30 մլն
Depreciation and amortization charges
89,01 մլն
90,29 մլն
166,61 մլն
109,49 մլն
EBITDA
-15,99 մլն
10,45 մլն
269,63 մլն
119,14 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps